UNDERWRITING AGREEMENT Perrigo Company plc 5,921,053 Ordinary Shares, par value €0.001 per shareUnderwriting Agreement • November 21st, 2014 • PERRIGO Co PLC • Pharmaceutical preparations • New York
Perrigo Company plc, a public limited company incorporated under the laws of Ireland (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 5,921,053 ordinary shares, par value €0.001 per share, of the Company (the “Underwritten Shares”) and up to an additional 888,157 ordinary shares, par value €0.001 per share, of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of ordinary shares, par value €0.001 per share, of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 12th, 2013 • PERRIGO Co LTD • Pharmaceutical preparations • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into on November 8, 2013, among Perrigo Company Limited, a limited company organized under the laws of Ireland (the“Company”), which will be re-registered as a public limited company and renamed Perrigo Company plc at or prior to the effective time of the Acquisition (as defined below), and shall, upon such re-registration, be the“Company“hereunder, Leopard Company, a Delaware Corporation (“Merger Sub”) and Habsont Limited, a company incorporated in Ireland (“Foreign Holdco” and, together with Merger Sub, the “Initial Guarantors”), and Barclays Capital Inc. (“Barclays”) and HSBC Securities (USA) Inc. (“HSBC”), acting as representatives (the “Representatives”) of the several initial purchasers listed on Schedule A to the Purchase Agreement (as defined below) (the “Initial Purchasers”). Upon consummation of the Acquisition, each of the Perrigo Guarantors (as defined in the Purchase Agreement), and within 60 days of
LIMITED LIABILITY COMPANY AGREEMENT OF PBM CANADA HOLDINGS, LLCLimited Liability Company Agreement • August 15th, 2014 • PERRIGO Co PLC • Pharmaceutical preparations • Delaware
This Limited Liability Company Agreement (this “Agreement”) of PBM CANADA HOLDINGS, LLC is entered into effective as of November 26, 2010 by PBM HOLDINGS, LLC, a Delaware limited liability company (the “Member”) pursuant to and in accordance with the Delaware Limited Liability Company Act (6 Del.C. § 18-101, et seq.), as amended from time to time (the “Act”).
PERRIGO COMPANY PLC RESTRICTED STOCK UNIT AWARD AGREEMENTRestricted Stock Unit Award Agreement • February 27th, 2020 • PERRIGO Co PLC • Pharmaceutical preparations • Michigan
This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the “Plan”), effective as of Grant Date (the “Grant Date”). This Award consists of service-based restricted stock units. The terms and conditions of this incentive are set forth in the remainder of this agreement (including any special terms and conditions set forth in any appendix for your country (“Appendix”) (collectively, the “Agreement”). The capitalized terms that are not otherwise defined in this Agreement shall have the meanings ascribed to such terms under the Plan.
NONQUALIFIED STOCK OPTION AGREEMENT (Under the Perrigo Company plc 2019 Long- Term Incentive Plan)Nonqualified Stock Option Agreement • February 27th, 2020 • PERRIGO Co PLC • Pharmaceutical preparations • Michigan
This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the “Plan”), effective as of Grant Date (the “Grant Date”). This Award consists of a nonqualified stock option. The terms and conditions of this incentive are set forth in the remainder of this agreement (including any special terms and conditions set forth in any appendix for your country (“Appendix”) (collectively, the “Agreement”). The capitalized terms that are not otherwise defined in this Agreement shall have the meanings ascribed to such terms under the Plan.
PERRIGO COMPANY PLC RESTRICTED STOCK UNIT AWARD AGREEMENTRestricted Stock Unit Award Agreement • February 27th, 2020 • PERRIGO Co PLC • Pharmaceutical preparations • Michigan
This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the “Plan”), effective as of Grant Date (the “Grant Date”). This Award consists of performance-based restricted stock units. The terms and conditions of this incentive are set forth in the remainder of this agreement (including any special terms and conditions set forth in any appendix for your country (“Appendix”) (collectively, the “Agreement”). The capitalized terms that are not otherwise defined in this Agreement shall have the meanings ascribed to such terms under the Plan.
EMPLOYMENT AGREEMENTEmployment Agreement • June 8th, 2023 • PERRIGO Co PLC • Pharmaceutical preparations • Michigan
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into, as of June 5, 2023 with employment commencing on June 30, 2023 (the “Effective Date”) by and between Perrigo Company, a Michigan corporation (the “Company”), and Patrick Lockwood-Taylor (“Executive”).
TERM LOAN CREDIT AGREEMENT dated as of August 15, 2019 among PERRIGO FINANCE UNLIMITED COMPANY, as Term Facility Borrower,Term Loan Credit Agreement • August 16th, 2019 • PERRIGO Co PLC • Pharmaceutical preparations • New York
This TERM LOAN CREDIT AGREEMENT (this “Agreement”), dated as of August 15, 2019, is among PERRIGO FINANCE UNLIMITED COMPANY, a public unlimited company organized under the laws of Ireland (the “Term Facility Borrower”), as Term Facility Borrower, PERRIGO COMPANY PLC, a public limited company organized under the laws of Ireland (the “Company”), as Company, the LENDERS party hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent, and WELLS FARGO BANK, NATIONAL ASSOCIATION and BANK OF AMERICA, N.A., as Syndication Agents.
STOCK AND ASSET PURCHASE AGREEMENT BY AND BETWEEN PERRIGO COMPANY PLC AND VESTAS PHARMA LLC Dated as of March 1, 2021Stock and Asset Purchase Agreement • March 2nd, 2021 • PERRIGO Co PLC • Pharmaceutical preparations • Delaware
This STOCK AND ASSET PURCHASE AGREEMENT, dated as of March 1, 2021 (this “Agreement”), is by and between PERRIGO COMPANY PLC, an Irish public limited company (“Seller”), and VESTAS PHARMA LLC, a Delaware limited liability company (“Purchaser”). Seller and Purchaser are each referred to as a “Party” and collectively as the “Parties.”
REVOLVING CREDIT AGREEMENTRevolving Credit Agreement • December 15th, 2015 • PERRIGO Co PLC • Pharmaceutical preparations • New York
This REVOLVING CREDIT AGREEMENT (this “Agreement”), dated as of December 9, 2015, is among PERRIGO FINANCE UNLIMITED COMPANY (formerly Perrigo Finance PLC), a public unlimited company organized under the laws of Ireland (the “Revolving Borrower”), as Revolving Borrower, PERRIGO COMPANY PLC, a public limited company organized under the laws of Ireland (the “Company”), the LENDERS party hereto, HSBC Bank USA, N.A., as Administrative Agent, and Bank of America, N.A. and Morgan Stanley Senior Funding, Inc., as Syndication Agents.
PERRIGO COMPANY PLC RESTRICTED STOCK UNIT AWARD AGREEMENTRestricted Stock Unit Award Agreement • February 25th, 2016 • PERRIGO Co PLC • Pharmaceutical preparations
This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award under the Perrigo Company plc 2013 Long-Term Incentive Plan (the “Plan”), effective as of ______________________ (the “Grant Date”). This Award consists of service-based restricted stock units. The terms and conditions of this incentive are set forth in the remainder of this agreement (the “Agreement”). The capitalized terms that are not otherwise defined in this Agreement shall have the meanings ascribed to such terms under the Plan.
Cash Bridge AmendmentCash Bridge Credit Agreement • February 6th, 2014 • PERRIGO Co PLC • Pharmaceutical preparations • New York
Reference is made to that certain Cash Bridge Credit Agreement dated as of July 28, 2013 (as may be amended, restated, amended and restated, extended, supplemented or otherwise modified in writing from time to time prior to the date hereof in accordance with its terms, the Agreement; the terms defined therein being used herein as therein defined), between Perrigo Company plc (formerly known as Perrigo Company Limited and formerly known as Blisfont Limited) a public limited company duly incorporated, registered and validly existing under the laws of Ireland (the Borrower), the Lenders party thereto, Barclays Bank PLC, as Administrative Agent, and HSBC Bank USA, N.A., as Syndication Agent.
INDEMNITY AGREEMENTIndemnity Agreement • December 19th, 2013 • PERRIGO Co PLC • Pharmaceutical preparations • Michigan
This Indemnity Agreement (this “Agreement”) is made as of [Date], by and between Perrigo Company, a Michigan corporation (the “Company”), 515 Eastern Avenue, Allegan, Michigan 49010, and [Name] (“Indemnitee”), whose address is [Address].
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • May 9th, 2019 • PERRIGO Co PLC • Pharmaceutical preparations
The Employment Agreement made and entered into effective October 8, 2018 by and between Perrigo Management Company (the “Company”) and Murray Kessler (“Executive”), is hereby Amended by this Amendment No. 1, effective as of February 13, 2019 (this “Amendment”).
TERM LOAN CREDIT AGREEMENT dated as of September 6, 2013 among PERRIGO COMPANY LIMITED, as Term Facility Borrower, THE LENDERS PARTY HERETO, BARCLAYS BANK PLC, as Administrative Agent HSBC BANK USA, N.A., as Syndication Agent BANK OF AMERICA, N.A.,...Term Loan Credit Agreement • September 13th, 2013 • PERRIGO Co LTD • Pharmaceutical preparations • New York
This TERM LOAN CREDIT AGREEMENT (this “Agreement”), dated as of September 6, 2013, is among PERRIGO COMPANY LIMITED, formerly known as BLISFONT LIMITED, a private limited company organized under the laws of Ireland (the “Term Facility Borrower”), as Term Facility Borrower, the LENDERS party hereto, BARCLAYS BANK PLC, as Administrative Agent, HSBC BANK USA, N.A., as Syndication Agent, and BANK OF AMERICA, N.A., JPMORGAN CHASE BANK, N.A. and WELLS FARGO BANK, NATIONAL ASSOCIATION as Documentation Agents.
ContractPERRIGO Co PLC • December 9th, 2021 • Pharmaceutical preparations • New York
This AMENDMENT NO. 2 (this “Amendment No. 2”), dated as of December 3, 2021 and entered into by and among Perrigo Finance Unlimited Company, a public unlimited company organized under the laws of Ireland (the “Term Facility Borrower”), Perrigo Company PLC, a public limited company organized under the laws of Ireland (the “Company”), each lender party hereto (each a “Consenting Lender” and, collectively, the “Consenting Lenders”) and JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “Administrative Agent”), amends and is made pursuant to that certain Term Loan Credit Agreement, dated as of August 15, 2019 (as amended by Amendment No. 1 and Waiver, dated as of August 10, 2021, and as further amended, restated, supplemented, waived or otherwise modified from time to time prior to the date hereof, the “Credit Agreement”), by and among the Term Facility Borrower, the Company, the lenders from time to time party thereto, the Administrative Agent and the other agents p
OPERATING AGREEMENT OF MERIDIAN ANIMAL HEALTH, LLCOperating Agreement • August 15th, 2014 • PERRIGO Co PLC • Pharmaceutical preparations • Nevada
This Operating Agreement (this “Agreement”) of MERIDIAN ANIMAL HEALTH, LLC is entered into and effective as of November 18, 2013 by SERGEANT’S PET CARE PRODUCTS, INC., a Michigan corporation (the “Member”) pursuant to and in accordance with Chapter 86 of the Nevada Revised Statutes (NRS 86.011, et seq.), as amended from time to time (the “Act”). This Agreement supersedes and completely replaces that certain Company Agreement of Meridian Animal Health, LLC dated as of January 28, 2008, as amended.
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • June 5th, 2017 • PERRIGO Co PLC • Pharmaceutical preparations
The Employment Agreement made and entered into effective August 3, 2016 (the “Agreement”), by and among Perrigo Company plc, a public limited company incorporated in Ireland (“Parent”), Perrigo Management Company, a Michigan corporation and a subsidiary of Parent (the “Company”), and John T. Hendrickson (“Executive”) is hereby amended by this Amendment No. 1, effective as of June 5, 2017 (this “Amendment”).
INDEMNITY AGREEMENTIndemnity Agreement • December 19th, 2013 • PERRIGO Co PLC • Pharmaceutical preparations
This Indemnity Agreement (this “Agreement”) is made as of [Date], by and between Perrigo Company plc, an Irish public limited company (the “Company”), having its registered office at 33 Sir John Rogerson’s Quay, Dublin 2, and [Name] (“Indemnitee”), whose address is [Address].
AMENDMENT AGREEMENT TO THE STOCK ESCROW AGREEMENT DATED 30 MARCH 2015The Stock Escrow Agreement • August 9th, 2018 • PERRIGO Co PLC • Pharmaceutical preparations
This AMENDMENT AGREEMENT (the ‘Amendment Agreement”) is made and entered into as 11 June 2018, by and among, Alychlo NV, a limited liability company incorporated under the laws of Belgium, with registered office at Lembergsesteenweg 19, 9820 Merelbeke, and registered under number 0895.140.645 (“Alychlo”), Perrigo Company pic, a public limited liability company incorporated tinder the laws of Ireland (“Perrigo Topco’) and Perrigo Ireland 2, a private company limited by shares incorporated under the laws of Ireland, each with registered office at Treasury Building, Lower Grand Canal Street, Dublin (the •‘Purchaser"!, and Computershare Inc., a Delaware corporation, and its wholly-owned subsidiary, Computershare Trust Company, N A., a federally chartered trust company, (collectively, 'Escrow. Agent) (all collectively referred to as the “Parties'’)
Amendment of clause 13.2 (a) of the Omega Pharma SPAPERRIGO Co PLC • May 22nd, 2017 • Pharmaceutical preparations
Reference is made to clause 13.2 (Non-compete and non-solicitation) of the sale and purchase agreement dated 6 November 2014 between Perrigo Company Plc (which assigned its rights and obligations to Perrigo Ireland 2 DAC), Holdco I BE NV and Alychlo NV, as amended per 27 April 2016, with respect to 95.77% of the shares in Omega Pharma Invest NV (the Omega Pharma SPA).
REVOLVING CREDIT AGREEMENT dated as of March 8, 2018 among PERRIGO FINANCE UNLIMITED COMPANY, as Revolving Borrower, PERRIGO COMPANY PLC, as Company, THE LENDERS PARTY HERETO, JPMORGAN CHASE BANK, N.A., as Administrative Agent, HSBC BANK USA, N.A. and...Revolving Credit Agreement • March 9th, 2018 • PERRIGO Co PLC • Pharmaceutical preparations • New York
This REVOLVING CREDIT AGREEMENT (this “Agreement”), dated as of March 8, 2018, is among PERRIGO FINANCE UNLIMITED COMPANY, a public unlimited company organized under the laws of Ireland (the “Revolving Borrower”), as Revolving Borrower, PERRIGO COMPANY PLC, a public limited company organized under the laws of Ireland (the “Company”), the LENDERS party hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent, Wells Fargo Bank, National Association and HSBC Bank USA, N.A., as Syndication Agents, and Bank of America, N.A., Barclays Bank PLC, Citibank, N.A., Credit Suisse AG, Cayman Islands Branch and Deutsche Bank Securities Inc., as Documentation Agents.
ContractPERRIGO Co PLC • March 16th, 2017 • Pharmaceutical preparations • New York
This AMENDMENT NO. 4 (this “Amendment No. 4”), dated as of March 14, 2017 and entered into by and among Perrigo Finance Unlimited Company (formerly Perrigo Finance PLC), a public unlimited company organized under the laws of Ireland (the “Revolving Borrower”), Perrigo Company PLC, a public limited company organized under the laws of Ireland (the “Company”), certain Lenders listed on the signature pages hereto (the “Consenting Lenders”) and JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “Administrative Agent”), amends that certain Revolving Credit Agreement, dated as of December 5, 2014 (as amended by Amendment No. 1, dated as of February 26, 2016, Amendment No. 2, dated as of September 9, 2016, and Amendment No. 3, dated as of December 8, 2016, and as further amended, restated, supplemented, waived or otherwise modified from time to time prior to the date hereof, the “Credit Agreement”), by and among the Revolving Borrower, the Company, the lenders party ther
PERRIGO FINANCE UNLIMITED COMPANY, as the Issuer, PERRIGO COMPANY PLC, as the Parent Guarantor and WELLS FARGO BANK, NATIONAL ASSOCIATION, as the Trustee SUPPLEMENTAL INDENTURE NO. 3 DATED AS OF June 19, 2020 TO INDENTURE DATED AS OF DECEMBER 2, 2014...PERRIGO Co PLC • June 19th, 2020 • Pharmaceutical preparations • New York
SUPPLEMENTAL INDENTURE NO. 3, dated as of June 19, 2020 (this “Supplemental Indenture”), among Perrigo Finance Unlimited Company, a public unlimited company organized under the law of Ireland (formerly, Perrigo Finance plc) (the “Issuer”), Perrigo Company plc, a public limited company organized under the law of Ireland (the “Parent” or the “Parent Guarantor”), and Wells Fargo Bank, National Association, a national banking association, as trustee (the “Trustee”), to the Base Indenture (as defined below).
MANAGEMENT AGREEMENTManagement Agreement • February 27th, 2020 • PERRIGO Co PLC • Pharmaceutical preparations
ContractPERRIGO Co PLC • September 9th, 2016 • Pharmaceutical preparations • New York
This AMENDMENT (this “Amendment”), dated as of September 9, 2016 and entered into by and among Perrigo Finance Unlimited Company (formerly Perrigo Finance PLC), a public unlimited company organized under the laws of Ireland (the “Revolving Borrower”), Perrigo Company PLC, a public limited company organized under the laws of Ireland (the “Company”), certain Lenders listed on the signature pages hereto (the “Consenting Lenders”), and JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “Administrative Agent”), amends that certain Revolving Credit Agreement, dated as of December 5, 2014 (as amended by Amendment No. 1, dated as of February 26, 2016, and as further amended, restated, supplemented, waived or otherwise modified from time to time prior to the date hereof, the “Credit Agreement”), by and among the Revolving Borrower, the Company, the lenders party thereto, the Administrative Agent and the other agents party thereto.
PERRIGO COMPANY PLC RESTRICTED STOCK UNIT AWARD AGREEMENT (SERVICE-BASED) (Under the Perrigo Company plc 2019 Long-Term Incentive Plan)Restricted Stock Unit Award Agreement • June 8th, 2023 • PERRIGO Co PLC • Pharmaceutical preparations • Michigan
This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the “Plan”), effective as of Grant Date (the “Grant Date”). This Award consists of service-based restricted stock units. The terms and conditions of this incentive are set forth in the remainder of this agreement (including any special terms and conditions set forth in any appendix for your country (“Appendix”) (collectively, the “Agreement”). The capitalized terms that are not otherwise defined in this Agreement shall have the meanings ascribed to such terms under the Plan.
OPERATING AGREEMENT OF PBM PRODUCTS, LLCOperating Agreement • August 15th, 2014 • PERRIGO Co PLC • Pharmaceutical preparations • Delaware
THIS OPERATING AGREEMENT, dated as of , 2004, is made and entered into by PBM Products, LLC, a Delaware limited liability company (the “Company”) and the Members (as such capitalized term and other capitalized terms are defined below in Section 1).
US.359387005.04 Initials _____ September 29, 2023 PERSONAL AND CONFIDENTIAL Mr. James Dillard III RE: Employment Separation and Severance Perrigo Company Confidential Wavier and Release Agreement Dear Jim: Your employment with Perrigo Company will end...Waiver and Release Agreement • February 27th, 2024 • PERRIGO Co PLC • Pharmaceutical preparations
PERRIGO COMPANY PLC RESTRICTED STOCK UNIT AWARD AGREEMENTRestricted Stock Unit Award Agreement • May 30th, 2017 • PERRIGO Co PLC • Pharmaceutical preparations • Michigan
This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award under the Perrigo Company plc 2013 Long-Term Incentive Plan (the “Plan”), effective as of ______________________ (the “Grant Date”). This Award consists of performance-based restricted stock units. The terms and conditions of this incentive are set forth in the remainder of this agreement (the “Agreement”). The capitalized terms that are not otherwise defined in this Agreement shall have the meanings ascribed to such terms under the Plan.
PERRIGO FINANCE UNLIMITED COMPANY, as the Issuer, PERRIGO COMPANY PLC, as the Parent Guarantor and WELLS FARGO BANK, NATIONAL ASSOCIATION, as the Trustee SUPPLEMENTAL INDENTURE NO. 2 DATED AS OF MARCH 10, 2016 TO INDENTURE DATED AS OF DECEMBER 2, 2014...Indenture • March 10th, 2016 • PERRIGO Co PLC • Pharmaceutical preparations • New York
SUPPLEMENTAL INDENTURE NO. 2, dated as of March 10, 2016 (this “Supplemental Indenture”), among Perrigo Finance Unlimited Company, a public unlimited company organized under the law of Ireland (formerly, Perrigo Finance plc) (the “Issuer”), Perrigo Company plc, a public limited company organized under the law of Ireland (the “Parent” or the “Parent Guarantor”), and Wells Fargo Bank, National Association, a national banking association, as trustee (the “Trustee”), to the Base Indenture (as defined below).
PERRIGO COMPANY PLC RESTRICTED STOCK UNIT AWARD AGREEMENT FOR NON-U.S. PARTICIPANTSRestricted Stock Unit Award Agreement • November 2nd, 2015 • PERRIGO Co PLC • Pharmaceutical preparations • Michigan
This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award for non-U.S. participants under the Perrigo Company plc 2013 Long-Term Incentive Plan (the “Plan”), effective as of ______________________ (the “Grant Date”). This Award consists of performance-based restricted stock units. The terms and conditions of this incentive are set forth in the remainder of this agreement (including any special terms and conditions set forth in any appendix for your country (“Appendix”)) (collectively, the “Agreement”). The capitalized terms that are not otherwise defined in this Agreement shall have the meanings ascribed to such terms under the Plan.
PERRIGO COMPANY PLC RESTRICTED STOCK UNIT AWARD AGREEMENT (SERVICE-BASED) (Under the Perrigo Company plc 2013 Long-Term Incentive Plan)Restricted Stock Unit Award Agreement • June 22nd, 2015 • PERRIGO Co PLC • Pharmaceutical preparations • Michigan
This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award under the Perrigo Company plc 2013 Long-Term Incentive Plan (the “Plan”), effective as of (the “Grant Date”). This Award consists of service-based restricted stock units. The terms and conditions of this incentive are set forth in the remainder of this agreement (the “Agreement”). The capitalized terms that are not otherwise defined in this Agreement shall have the meanings ascribed to such terms under the Plan.
OPERATING AGREEMENT OF FIDOPHARMBRANDS, LLCOperating Agreement • August 15th, 2014 • PERRIGO Co PLC • Pharmaceutical preparations • Delaware
THIS OPERATING AGREEMENT of FidoPharmBrands, LLC, a Delaware limited liability company (the “Company”) is made effective as of January 1, 2012 (the “Effective Date”), by the Company’s sole member, Velcera, Inc., a Delaware corporation (the “Member”).
WAIVER TO NOTE PURCHASE AGREEMENTNote Purchase Agreement • May 16th, 2016 • PERRIGO Co PLC • Pharmaceutical preparations
This WAIVER TO NOTE PURCHASE AGREEMENT dated as of May 16, 2016 (this “Waiver”) to the Note Purchase Agreement (as defined below) is between Omega Pharma N.V., a company incorporated with limited liability in Belgium (the “Company”), and each of the institutions which is a signatory to this Waiver (collectively, the “Noteholders”).
